Skip navigation

Strategic Forecasting, Accounting Estimates, Analytics and Financial Reporting for Life Science Companies

November 15-16, 2017
  • Philadelphia, PA
The definitive industry GTN event that convenes over 300 Accounting, Finance, Managed Markets and Contract Analytics executives each year!

Proactive and strategic management of GTN is critical for life science companies of all sizes and all stages of maturity. Whether your organization is pre-commercial revenue or is managing multiple products and large revenue streams, an understanding of GTN models and processes is paramount to success and compliance. CBI’s longstanding Gross-to-Net Summit is built for the learning needs and changing dynamics of pharmaceutical, biotech and generic drug companies. Attendees gain best practices for a well-designed, multi-faceted approach to GTN management for enhanced visibility, profitability and control.

Earn
CPE Credits!
Pending Approval

This in-depth event showcases industry models for GTN estimates, analytics and reporting, offers multiple workshops and features three tracks of relevant and timely content. Attendees choose from Branded Pharma, Generic Products and Emerging Biotech, with streams of sessions tailored to your business needs.

This In-Depth Event Arms You with Strategies to:

  • Accurately capture, monitor and report GTN data
  • Forecast and plan for GTN liabilities
  • Estimate product returns with little to no historical data
  • Manage GTN for return accruals, new product launches and
    patent expiries/discontinuation/recalls
  • Report and understand indirect/non-contracted sales
  • Account for coupon, copay and voucher programs
  • Anticipate and substantiate shifts in chargebacks
  • Assess the financial impact of Healthcare reform

AUDIENCE ACCLAIM FROM CBI’S FINANCIAL SERIES:

Excellent opportunity to network with peers and opportunity to meet software vendors and solution providers.

Chief Financial Officer, Kowa Pharmaceuticals

The CBI Gross-to-Net Conference offers a broad range of experiences and knowledge to help navigate this
complex and unclear critical business area.

Manager, Chargebacks, Fresenius Kabi

A premier event for finance professionals in the healthcare industry… Would be difficult to surpass.

Worldwide Biopharma Business Controller, Pfizer Inc

GTN 2017 | Gross-to-Net Summit

Strategic Forecasting, Accounting Estimates, Analytics and Financial Reporting for Life Science Companies

The definitive industry GTN event that convenes over 300 Accounting, Finance, Managed Markets and Contract Analytics executives each year!

Proactive and strategic management of GTN is critical for life science companies of all sizes and all stages of maturity. Whether your organization is pre-commercial revenue or is managing multiple products and large revenue streams, an understanding of GTN models and processes is paramount to success and compliance. CBI’s longstanding Gross-to-Net Summit is built for the learning needs and changing dynamics of pharmaceutical, biotech and generic drug companies. Attendees gain best practices for a well-designed, multi-faceted approach to GTN management for enhanced visibility, profitability and control.

Earn
CPE Credits!
Pending Approval

This in-depth event showcases industry models for GTN estimates, analytics and reporting, offers multiple workshops and features three tracks of relevant and timely content. Attendees choose from Branded Pharma, Generic Products and Emerging Biotech, with streams of sessions tailored to your business needs.

This In-Depth Event Arms You with Strategies to:

  • Accurately capture, monitor and report GTN data
  • Forecast and plan for GTN liabilities
  • Estimate product returns with little to no historical data
  • Manage GTN for return accruals, new product launches and
    patent expiries/discontinuation/recalls
  • Report and understand indirect/non-contracted sales
  • Account for coupon, copay and voucher programs
  • Anticipate and substantiate shifts in chargebacks
  • Assess the financial impact of Healthcare reform

AUDIENCE ACCLAIM FROM CBI’S FINANCIAL SERIES:

Excellent opportunity to network with peers and opportunity to meet software vendors and solution providers.

Chief Financial Officer, Kowa Pharmaceuticals

The CBI Gross-to-Net Conference offers a broad range of experiences and knowledge to help navigate this
complex and unclear critical business area.

Manager, Chargebacks, Fresenius Kabi

A premier event for finance professionals in the healthcare industry… Would be difficult to surpass.

Worldwide Biopharma Business Controller, Pfizer Inc